9 April 2025 · An update supporting implementation of biosimilar and key generic medicines for aflibercept, golimumab, nilotinib and ferric carboxymaltose.
26 March 2025 · Discussion of key current medication safety challenges within healthcare with a focus on the safe use of insulin; inspiring partnership across the system.
4 March 2025 · A consultant pharmacist used case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.
28 February 2025 · SPS will be at CPC London 2025. Visit our stand and listen to our presentations at this award winning conference. 9th and 10th May 2025.
25 February 2025 · An update for those involved in medicines governance including managing PGDs and other medicine mechanisms in practice. 13th May 2025.
11 February 2025 · An insight on principles of patient centred structured medication reviews; using the current evidence and shared decision making to facilitate de-prescribing.
23 January 2025 · An SPS Quality Assurance (QA) bite size learning event on evaluating chemical and physical stability of aseptically prepared medicines.